
Deficiency in androgens and upregulation of insulin-like growth factor-1 are involved in high bone turnover in men receiving androgen deprivation therapy for prostate cancer
Keywords: BMD، تراکم معدنی استخوان; ADT, androgen deprivation therapy; BMD, bone mineral density; BMI, body mass index; DHEA-S, dihydroepiandrosterone sulfate; IGF-I, insulin-like growth factor-1; PTH, parathyroid hormone; NTx, N-telopeptide; BAP, bone-specific alkaline phosphatase; DPD, de